Real-world evaluation of treatment patterns and clinical outcomes among patients with primary mediastinal large B-cell lymphoma treated with brentuximab vedotin (BV)–based treatment options in China.
Authors: Hengge Xu, Wei Li, Ningning Zhang, Xianhuo Wang, Huilai Zhang
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e19058
Source:
Full article
Abstract
e19058